Lina Sui serves as the Senior Director of Analytical Development at Sana Biotechnology, Inc., where she leverages her extensive expertise in stem cell biology to drive innovative solutions in cell therapy. With over 16 years of experience in human embryonic stem cell (hESC) culture and...
Lina Sui serves as the Senior Director of Analytical Development at Sana Biotechnology, Inc., where she leverages her extensive expertise in stem cell biology to drive innovative solutions in cell therapy. With over 16 years of experience in human embryonic stem cell (hESC) culture and the reprogramming of human induced pluripotent stem cells (iPSCs), Lina has become a pivotal figure in advancing allogeneic CAR T cell therapy and iPSC cell therapy. Her current role involves overseeing critical analytical processes that ensure the efficacy and safety of cellular therapies, particularly in the context of diabetes modeling and the differentiation of pancreatic beta cells from iPSCs.
At Sana, Lina is spearheading key projects that focus on optimizing the differentiation protocols for pancreatic beta cells, a crucial step in developing effective cell therapies for diabetes. Her work encompasses the establishment of robust cellular and molecular assays that monitor critical parameters throughout the differentiation process, ensuring that the resulting cells meet the stringent requirements for therapeutic applications. Lina's proficiency in CRISPR/Cas9 gene editing further enhances her contributions, allowing for precise modifications that can improve the functionality and safety of engineered cells.
In addition to her technical skills in cell culture, immunohistochemistry, and Western blotting, Lina is committed to fostering collaborative efforts within multidisciplinary teams to accelerate the translation of scientific discoveries into viable treatments. Her deep understanding of in vitro and in vivo models positions her as a leader in the field, driving forward the mission of Sana Biotechnology to harness the power of cell therapy for transformative healthcare solutions.